Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Citi
Merck
Accenture
Colorcon
McKinsey
Julphar
Healthtrust
Chinese Patent Office
Farmers Insurance

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021925

« Back to Dashboard

NDA 021925 describes DUETACT, which is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the DUETACT profile page.

The generic ingredient in DUETACT is glimepiride; pioglitazone hydrochloride. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glimepiride; pioglitazone hydrochloride profile page.
Summary for 021925
Tradename:DUETACT
Applicant:Takeda Pharms Usa
Ingredient:glimepiride; pioglitazone hydrochloride
Patents:2
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021925
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925 NDA Takeda Pharmaceuticals America, Inc. 64764-302 N 64764-302-30
DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925 NDA Takeda Pharmaceuticals America, Inc. 64764-302 N 64764-302-90

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG;30MG
Approval Date:Jul 28, 2006TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jan 30, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Jun 8, 2028Product Flag?YSubstance Flag?Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG;30MG
Approval Date:Jul 28, 2006TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jan 30, 2027Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021925

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-002 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-002 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-001 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-001 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-002 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-001 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-001 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-002 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-001 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Usa DUETACT glimepiride; pioglitazone hydrochloride TABLET;ORAL 021925-002 Jul 28, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Boehringer Ingelheim
Dow
AstraZeneca
US Department of Justice
Mallinckrodt
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot